Wyeth Pharmaceuticals
Records under this name other than patents Wyeth Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Wyeth Pharmaceuticals
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,618,632 | A Method of Treating or Ameliorating an Immune Cell Associated Pathology Using Gitr Ligand Antibodies Formerly held Term ended Term ended Apr 20, 2025 · High confidence | Term ended | Term ended Apr 20, 2025 | High confidence |
| US 7,390,786 | Protein formulations with reduced viscosity and uses thereof Formerly held Lapsed on the fee record Ended Jun 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 24, 2020 | From the USPTO record |
| US 6,500,814 | Hormonal contraceptive Term ended Term ended Jun 5, 2020 · From the USPTO record | Term ended | Term ended Jun 5, 2020 | From the USPTO record |
| US 8,811,696 | Morphometry of the human hip joint and prediction of osteoarthritis Formerly held Lapsed on the fee record Ended Aug 19, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2018 | From the USPTO record |
| US 8,582,843 | Morphometry of the human knee joint and prediction for osteoarthritis Formerly held Lapsed on the fee record Ended Nov 12, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2017 | From the USPTO record |
| US 6,177,477 | Propofol formulation containing TRIS Formerly held Lapsed on the fee record Ended Jan 23, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jan 23, 2009 | From the USPTO record |
| US 6,028,108 | Propofol composition comprising pentetate Formerly held Lapsed on the fee record Ended Feb 22, 2008 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2008 | From the USPTO record |